CSL Plasma

CSL Plasma is steeped in a tradition of innovation and excellence. We’re a wholly owned subsidiary of CSL Behring, headquartered in King of Prussia, Pennsylvania. Other facilities include a manufacturing plant in Kankakee, Illinois, and facilities in Broadmeadows, Australia, Marburg, Germany and Bern, Switzerland. The Behring name honors the scientific efforts by founder Emil von Behring, whose serum therapy was awarded the Nobel Prize in 1901.

 

CSL Plasma and CSL Behring are owned by a larger group, CSL Limited, based in Melbourne, Australia. CSL first began in 1916 by supplying vaccines for the Australian government. In 1994, CSL became a public company, listed on the Australian Stock Exchange. Since then, CSL Limited has grown rapidly to become a successful and well-respected global specialty biopharmaceutical company. CSL currently employs over 10,500 associates worldwide.

 

We couldn’t ask to be in a more satisfying business. And we take that satisfaction into everything we do. This means we strive to act with the utmost integrity as we take care of the plasma collected as well as our valued employees and donors. You can see how we act on our commitment in any of our US collection facilities, our corporate headquarters in Boca Raton, Florida, our logistics center in Indianapolis, Indiana, our laboratory testing facilities in Knoxville, Tennessee and all of our operations in Germany.